LYRM03
LYRM03 is a ubenimex-derived aminopeptidase inhibitor that attenuates LPS-induced acute lung injury in mice. It functions by suppressing pro-inflammatory mediator expression and inhibiting MyD88-dependent TLR4 signaling in alveolar macrophages, highlighting its potential for sepsis-related lung injury research.
Product Specifications
CAS Number
1820750-36-4
Smiles
[C@H] (C (N[C@@H] ([C@H] (CC) C) C (O) =O) =O) (NC ([C@H] ([C@@H] (CC1=CC=CC=C1) N) O) =O) C (C) C
Molecular Formula
C21H33N3O5
Molecular Weight
407.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TMAY-01540H-01 20 µg
Anti-Human respiratory syncytial virus (RSV) (A2) Fusion glycoprotein/RSV-F Antibody-HRP (8L753)
Sign In for Pricing
View Details TMAY-01540H-02 100 µg
Anti-Human respiratory syncytial virus (RSV) (A2) Fusion glycoprotein/RSV-F Antibody-HRP (8L753)
Sign In for Pricing
View Details 
MBS2018151-01 0.1 mL
FITC-linked Antibody to Melanoma Cell Adhesion Molecule (MCAM)
Sign In for Pricing
View Details MBS2018151-02 0.2 mL
FITC-linked Antibody to Melanoma Cell Adhesion Molecule (MCAM)
Sign In for Pricing
View Details MBS2018151-03 0.5 mL
FITC-linked Antibody to Melanoma Cell Adhesion Molecule (MCAM)
Sign In for Pricing
View Details